Skip to main content
OpenTrials
Completed

NCT Number: NCT02931396

Functional Electrical Stimulation Use in Trans-tibial Amputations

The purpose of this study is to demonstrate the efficacy of functional electrical stimulation (FES) for trans-tibial amputees. The investigators aim to demonstrate that providing three months of FES intervention will increase knee extension strength, increase volume of the residual limb and decrease chronic and phantom pain.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Pittsburgh

Pittsburgh, Pennsylvania, 15206, United States

About this study

SUMMARY STUDY GOALS: The purpose of this study is to demonstrate the efficacy of FES for trans-tibial amputees. The investigators aim to demonstrate that providing three months of FES intervention will increase knee extension strength, increase volume of the residual limb and decrease chronic and phantom pain.

EXPERIMENTAL DESIGN: Randomized control trial METHODS: Twenty participants will be recruited and randomly divided into two groups, one group will receive the FES intervention while the other group will continue with activities of daily living. Both groups will keep a daily log of number of hours the prosthesis is worn, number of hours the FES is worn (if used) and any changes in skin conditions or medications. Both groups will return for assessment visits at 4, 8, and 12 weeks and a follow up visit 3 months post-intervention for investigators to inspect the residual limb and check the fit of the prosthetic socket, record residual limb knee extension strength on the Biodex machine, take measurements (circumferences and lengths) of the residual limb with a tape measure and ruler, scan the limb with the hand held three-dimensional motion-tracking laser scanner system and the participant will be asked to complete a pain questionnaire. The Prosthetic Evaluation Questionnaire (PEQ) will be completed at the 12 week and the 3 month follow-up visits. Although outcomes data were captured during each assessment visit (0, 4, 8 and 12 weeks and 3 months), changes in the primary outcomes (strength, volume and pain) at timepoints 0 weeks (pre-intervention) and 12 weeks (post- intervention) were of primary interest.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women over 18 years of age.
  • Participants have a unilateral trans-tibial amputation with a minimum of a 4" residual limb. This length of amputation was chosen to provide for adequate surface area for the electrodes.
  • Participants must be a minimum of two years postoperative to insure proper healing of the limb has occurred.
  • Participants have chronic limb pain.
  • No prior experience in using TENS or FES.

Exclusion criteria

  • No cardiac conditions, such as hypertension, congestive heart failure, or a pacemaker.
  • People with severe diabetes who have insensate skin and or neuropathy.

Treatment and study plan

FES

Device

Primary outcomes

  1. Change in Knee Extension Isometric Strength (Peak Torque) Using the Biodex Measurement System

    Time frame: baseline and 12 weeks

    Residual limb knee extension isometric strength was tested using a standardized Biodex protocol and custom attachment. The lever arm of the Biodex was positioned at 60 degrees of knee flexion, with the support cushion modified for the amputee and positioned at the mid-tibia. The participant was asked to extend their knee against the arm as hard as they could for five seconds.

  2. Change in Residual Limb Volume Using 3-D Scanner

    Time frame: baseline and 12 weeks

    3-D motion-tracking laser scanning system was used to determine residual limb volume in cm

  3. Change in Residual Limb Pain Using Likert Scale Pain Questionnaire

    Time frame: baseline and 12 weeks

    Scores were reported on a 0 to 10 scale with higher scores representing higher pain levels

Sponsors and collaborators

Lead sponsor

Alicia Koontz

Other

Registry information

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Oct 13, 2016
Registry last updated
Dec 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.